eGFR alto, basso e valori normali
Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy | Journal of Medicinal Chemistry
Frontiers | Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer
Piezo1 activates noncanonical EGFR endocytosis and signaling | Science Advances
mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme | SpringerLink
The EGFR-mTOR pathway. Schematic figure displaying the molecular... | Download Scientific Diagram
Materials | Free Full-Text | Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells
Epidermal growth factor receptor mutations in lung cancer | Nature Reviews Cancer
Cancers | Free Full-Text | Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text
Creatinina e funzione renale. Domande e risposte.
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
IJMS | Free Full-Text | The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer
EGFR blockade promotes morphological and functional rec | Open-i
Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors | Journal of Medicinal Chemistry
Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries | Molecular Pharmacology
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text
Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes - ScienceDirect
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer | Clinical and Translational Oncology
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components | Science Translational Medicine
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect
ERBB receptors and cancer: the complexity of targeted inhibitors | Nature Reviews Cancer
Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality
Kidney function trajectory in BBS subjects. (A) eGFR declines with age... | Download Scientific Diagram
Cetuximab–Polymersome–Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers | Biomacromolecules
